HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

SKB BIO-B

415.600

+4.0000.97%

Volume:215.00K

Turnover:89.18M

Market Cap:96.91B

PE:-316.50

High:418.600

Open:417.800

Low:409.400

Close:411.600

52wk High:581.000

52wk Low:152.000

Shares:233.19M

HK Float Shares:162.77M

Volume Ratio:0.59

T/O Rate:0.13%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.313

ROE:-17.56%

ROA:-9.92%

PB:17.71

PE(LYR):-316.50

PS:59.19

Loading ...

Overview Company News Filings

Sichuan Kelun-Biotech (06990) Releases Monthly Return for October 2025

Bulletin Express

Merck Partners with Blackstone, Secures $700 Million to Accelerate Global Development of SKB BIO-B's (06990) Licensed Product Sac-TMT

Global Stocks That May Be Priced Below Their Estimated Value In November 2025

Simply Wall St.

HK Stock Movement | SKB BIO-B (06990) Rises Nearly 5% as Core Product SKB264 Selected for Two Oral Presentations at ESMO

Jiaoyin International Maintains "Buy" Rating for SKB BIO-B (06990), Target Price Raised to HKD 549

A Look at Kelun-Biotech (SEHK:6990) Valuation Following Breakthrough ADC Trial Results and New China Approvals

Simply Wall St.

ESMO Shines! China's "No. 1" ADC Takes the Stage

Positive Results From Phase 3 Optitrop-Lung04 Trial of Sacituzumab Tirumotecan Presented at Esmo Presidential Symposium and Simultaneously Published in Nejm

THOMSON REUTERS

HK Stock Movement | SKB BIO-B (06990) Opens Over 5% Higher, Announces Clinical Research Results at ESMO 2025 Conference

SKB BIO-B (06990) Unveils Multiple Innovative Drug Research Findings at 2025 ESMO Conference

Sichuan Kelun-Biotech Unveils Positive Results from Multiple Innovative Drug Studies at 2025 ESMO Congress

Kelun-Biotech Reports Positive Phase 3 Results for Sacituzumab Tirumotecan in Advanced HR+/HER2- Breast Cancer

Sichuan Kelun-Biotech’s Trastuzumab Botidotin Receives NMPA Approval for HER2-Positive Metastatic Breast Cancer in China

Kelun-Biotech (6990) Secures NMPA Approval for Trastuzumab Botidotin in HER2+ Metastatic Breast Cancer

Bulletin Express

SKB BIO-B (06990): Core Product A166 Approved by NMPA for 2L+ HER2+ Breast Cancer Treatment

BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Says NMPA Approves Trastuzumab Botidotin For Marketing

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd - Nmpa Approves Trastuzumab Botidotin for Marketing

THOMSON REUTERS

Analysis of Hong Kong Stocks | Favorable Conditions Strengthen Exchange Rates, Market Blossoms, Pharmaceuticals Worthy of Exploitation

Hong Kong Stocks Movement | Pharmaceutical Stocks Continue Multi-Day Decline Amid Short-Term External Environment Changes, Institutions Remain Optimistic About Long-Term Industry Development Trends

Hong Kong Stock Morning Brief | Congo's Cobalt Export Quota Takes Effect, Qualcomm Under Antitrust Investigation

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/06990/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06990","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"SKB BIO-B","latestPrice":415.6,"timestamp":1762486478642,"preClose":411.6,"halted":0,"volume":215000,"delay":0,"floatShares":162769979,"shares":233185969,"eps":-1.3131784795704946,"marketStatus":"Trading","change":4,"latestTime":"11-07 11:36:23","open":417.8,"high":418.6,"low":409.4,"amount":89179737,"amplitude":0.022352,"askPrice":416.2,"askSize":100,"bidPrice":415.4,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.4937782067909153,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1762488000000},"marketStatusCode":2,"adr":0,"listingDate":1689004800000,"exchange":"SEHK","adjPreClose":411.6,"openAndCloseTimeList":[[1762479000000,1762488000000],[1762491600000,1762502400000]],"volumeRatio":0.588019,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","floatShares":162769979,"roa":"-9.92%","roe":"-17.56%","lyrEps":-1.313106,"volumeRatio":0.588019,"shares":233185969,"dividePrice":0,"high":418.6,"amplitude":0.022352,"preClose":411.6,"low":409.4,"week52Low":152,"pbRate":"17.71","psRate":"59.19","week52High":581,"institutionHeld":0,"latestPrice":415.6,"eps":-1.3131061595851377,"divideRate":0,"volume":215000,"delay":0,"ttmEps":-3.4935857957876237,"open":417.8,"prevYearClose":163.3,"prevWeekClose":448,"prevMonthClose":448,"prevQuarterClose":514,"fiveDayClose":448,"twentyDayClose":510.5,"sixtyDayClose":403.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06990\",params:#limit:5,,,undefined,":[{"date":"2025-08-18","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-03-24","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"Post Market","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-19","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"Post Market","dateTimestamp":1723996800000,"actualEps":null},{"date":"2024-03-25","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null},{"date":"2023-08-28","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693186200000,"name":null,"time":"","dateTimestamp":1693152000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06990\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06990\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.5556,"hold":0.1111,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5556,"analysts":18,"updateTime":1755619200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06990\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06990","date":"2025-11-06","current":-118.161458,"percent":0.52,"low":-351.800852,"twenty":-203.932949,"median":-132.129081,"eighty":-48.609184,"high":-21.029201,"avg":-126.795211,"sd":82.579441,"marketCap":95979344840},"quantilePoints":[{"date":"2023-07-14","current":-21.13661,"twenty":-21.950454,"median":-21.915957,"eighty":-21.591449,"marketCap":14244687534},{"date":"2023-07-21","current":-23.970152,"twenty":-21.950454,"median":-21.798359,"eighty":-21.186829,"marketCap":16079230625},{"date":"2023-07-28","current":-25.171471,"twenty":-24.928642,"median":-21.953758,"eighty":-21.326081,"marketCap":16867005011},{"date":"2023-08-04","current":-23.795235,"twenty":-24.81024,"median":-23.425444,"eighty":-21.637654,"marketCap":15971316326},{"date":"2023-08-11","current":-25.354634,"twenty":-24.81024,"median":-23.323535,"eighty":-21.856149,"marketCap":16921892522},{"date":"2023-08-18","current":-27.290696,"twenty":-25.136334,"median":-23.811022,"eighty":-21.920213,"marketCap":18083628667},{"date":"2023-08-25","current":-27.955027,"twenty":-25.91111,"median":-24.066367,"eighty":-21.957062,"marketCap":18532979440},{"date":"2023-09-01","current":-41.23344,"twenty":-27.36684,"median":-24.766756,"eighty":-21.989236,"marketCap":16768455673},{"date":"2023-09-08","current":-41.179226,"twenty":-40.625811,"median":-24.994187,"eighty":-22.159386,"marketCap":16549260174},{"date":"2023-09-15","current":-42.756679,"twenty":-41.200358,"median":-25.354634,"eighty":-22.761005,"marketCap":17316444421},{"date":"2023-09-22","current":-42.808543,"twenty":-42.12743,"median":-25.915972,"eighty":-23.169807,"marketCap":17261645546},{"date":"2023-09-29","current":-41.568511,"twenty":-42.347449,"median":-27.197776,"eighty":-23.343916,"marketCap":16790375223},{"date":"2023-10-06","current":-41.914184,"twenty":-42.346401,"median":-27.481057,"eighty":-23.57336,"marketCap":16921892522},{"date":"2023-10-13","current":-45.021843,"twenty":-42.393899,"median":-34.166325,"eighty":-23.80155,"marketCap":18149387317},{"date":"2023-10-20","current":-39.509362,"twenty":-42.529229,"median":-40.304828,"eighty":-23.874674,"marketCap":15902633452},{"date":"2023-10-27","current":-41.923505,"twenty":-42.45246,"median":-40.317099,"eighty":-23.977981,"marketCap":16867093648},{"date":"2023-11-03","current":-44.17615,"twenty":-43.157759,"median":-40.968576,"eighty":-24.032126,"marketCap":17820594068},{"date":"2023-11-10","current":-48.451746,"twenty":-43.729096,"median":-41.213927,"eighty":-24.147781,"marketCap":19541278735},{"date":"2023-11-17","current":-48.422639,"twenty":-44.163404,"median":-41.246315,"eighty":-24.349478,"marketCap":19705675360},{"date":"2023-11-24","current":-47.973827,"twenty":-44.628759,"median":-41.529173,"eighty":-24.780872,"marketCap":19683755810},{"date":"2023-12-01","current":-50.941262,"twenty":-45.174782,"median":-41.90853,"eighty":-24.844962,"marketCap":20987969029},{"date":"2023-12-08","current":-50.880899,"twenty":-46.685504,"median":-41.9817,"eighty":-24.922954,"marketCap":20878371279},{"date":"2023-12-15","current":-53.058458,"twenty":-47.438439,"median":-42.172758,"eighty":-25.124621,"marketCap":21897630350},{"date":"2023-12-22","current":-55.272951,"twenty":-48.26932,"median":-42.355666,"eighty":-25.208104,"marketCap":22796331896},{"date":"2023-12-29","current":-54.398289,"twenty":-48.483234,"median":-42.389893,"eighty":-25.318001,"marketCap":22555216847},{"date":"2024-01-05","current":-54.305497,"twenty":-48.692055,"median":-42.518207,"eighty":-25.505631,"marketCap":22357940898},{"date":"2024-01-12","current":-58.852865,"twenty":-49.706536,"median":-42.808543,"eighty":-25.777515,"marketCap":24243022189},{"date":"2024-01-19","current":-48.649703,"twenty":-50.614438,"median":-43.44751,"eighty":-25.920835,"marketCap":20012549058},{"date":"2024-01-26","current":-45.202208,"twenty":-50.432693,"median":-43.523908,"eighty":-26.320623,"marketCap":18522019665},{"date":"2024-02-02","current":-38.832469,"twenty":-50.323187,"median":-43.65215,"eighty":-26.948338,"marketCap":15891673677},{"date":"2024-02-09","current":-43.972121,"twenty":-49.706536,"median":-43.780393,"eighty":-27.253528,"marketCap":18083628667},{"date":"2024-02-16","current":-51.156498,"twenty":-50.095577,"median":-43.99523,"eighty":-27.328768,"marketCap":21042767904},{"date":"2024-02-23","current":-57.052501,"twenty":-50.855188,"median":-44.095348,"eighty":-27.575851,"marketCap":23344320643},{"date":"2024-03-01","current":-55.517903,"twenty":-51.144997,"median":-44.174132,"eighty":-27.979787,"marketCap":22730573246},{"date":"2024-03-08","current":-62.556972,"twenty":-52.587613,"median":-44.308071,"eighty":-30.229554,"marketCap":25623953833},{"date":"2024-03-15","current":-80.340969,"twenty":-54.14227,"median":-44.794506,"eighty":-38.844663,"marketCap":32879324850},{"date":"2024-03-22","current":-87.812662,"twenty":-54.39157,"median":-45.089055,"eighty":-38.957109,"marketCap":35904222736},{"date":"2024-03-28","current":-54.646477,"twenty":-54.498503,"median":-45.202208,"eighty":-39.211798,"marketCap":33975302345},{"date":"2024-04-05","current":-48.790889,"twenty":-54.557693,"median":-45.399289,"eighty":-39.390336,"marketCap":30314737511},{"date":"2024-04-12","current":-51.407626,"twenty":-54.48688,"median":-46.006494,"eighty":-39.95604,"marketCap":31958703754},{"date":"2024-04-19","current":-48.134373,"twenty":-54.430626,"median":-46.386128,"eighty":-40.284427,"marketCap":29898266063},{"date":"2024-04-26","current":-71.709655,"twenty":-54.881886,"median":-46.751052,"eighty":-40.312191,"marketCap":36824843832},{"date":"2024-05-03","current":-70.050704,"twenty":-55.277405,"median":-46.894686,"eighty":-40.440284,"marketCap":35948061836},{"date":"2024-05-10","current":-80.537958,"twenty":-55.535893,"median":-47.299854,"eighty":-40.706984,"marketCap":41427949311},{"date":"2024-05-17","current":-72.846762,"twenty":-56.640749,"median":-47.434905,"eighty":-40.885351,"marketCap":37416671679},{"date":"2024-05-24","current":-76.490072,"twenty":-57.838988,"median":-47.480121,"eighty":-41.121673,"marketCap":39198277014},{"date":"2024-05-31","current":-74.804992,"twenty":-59.45269,"median":-48.0541,"eighty":-41.186166,"marketCap":38373753847},{"date":"2024-06-07","current":-77.551054,"twenty":-62.567703,"median":-48.422639,"eighty":-41.217553,"marketCap":39733102851},{"date":"2024-06-14","current":-71.048454,"twenty":-63.220056,"median":-48.609184,"eighty":-41.232055,"marketCap":36368156956},{"date":"2024-06-21","current":-75.38559,"twenty":-65.709636,"median":-48.654461,"eighty":-41.23344,"marketCap":38507460307},{"date":"2024-06-28","current":-72.361795,"twenty":-70.050704,"median":-48.790889,"eighty":-41.25919,"marketCap":36947551614},{"date":"2024-07-05","current":-71.32983,"twenty":-70.110492,"median":-48.913989,"eighty":-41.293743,"marketCap":36412725776},{"date":"2024-07-12","current":-64.338068,"twenty":-69.786991,"median":-49.290918,"eighty":-41.483815,"marketCap":32891789012},{"date":"2024-07-19","current":-64.816339,"twenty":-69.10708,"median":-50.290098,"eighty":-41.560643,"marketCap":33136917521},{"date":"2024-07-26","current":-64.836994,"twenty":-68.943217,"median":-50.396598,"eighty":-41.836002,"marketCap":33270623980},{"date":"2024-08-02","current":-67.177788,"twenty":-68.832021,"median":-50.583009,"eighty":-41.911922,"marketCap":34451697705},{"date":"2024-08-09","current":-67.337335,"twenty":-68.832021,"median":-50.91108,"eighty":-41.921641,"marketCap":34763679444},{"date":"2024-08-16","current":-69.468586,"twenty":-68.832021,"median":-51.098991,"eighty":-41.970061,"marketCap":35877899939},{"date":"2024-08-23","current":-143.952492,"twenty":-69.519081,"median":-51.282062,"eighty":-42.023931,"marketCap":36568716645},{"date":"2024-08-30","current":-142.905377,"twenty":-70.543671,"median":-51.775379,"eighty":-42.069838,"marketCap":36546432236},{"date":"2024-09-06","current":-147.713941,"twenty":-71.622574,"median":-52.451442,"eighty":-42.229208,"marketCap":37794359190},{"date":"2024-09-13","current":-159.71572,"twenty":-72.235174,"median":-53.058458,"eighty":-42.319371,"marketCap":40758185707},{"date":"2024-09-20","current":-153.295015,"twenty":-72.624329,"median":-53.663008,"eighty":-42.346401,"marketCap":39354267883},{"date":"2024-09-27","current":-152.378595,"twenty":-73.54444,"median":-54.299669,"eighty":-42.364187,"marketCap":39354267883},{"date":"2024-10-04","current":-188.785359,"twenty":-74.133327,"median":-54.381491,"eighty":-42.385888,"marketCap":48535444762},{"date":"2024-10-10","current":-168.292174,"twenty":-74.96999,"median":-54.488817,"eighty":-42.420555,"marketCap":42986626697},{"date":"2024-10-18","current":-169.261982,"twenty":-75.395206,"median":-54.742682,"eighty":-42.48514,"marketCap":43008911107},{"date":"2024-10-25","current":-173.131782,"twenty":-76.300948,"median":-55.181976,"eighty":-42.60999,"marketCap":43989425142},{"date":"2024-11-01","current":-155.135166,"twenty":-77.964709,"median":-55.298647,"eighty":-42.767052,"marketCap":39443405523},{"date":"2024-11-08","current":-154.553256,"twenty":-78.843611,"median":-55.532894,"eighty":-42.819467,"marketCap":38997717325},{"date":"2024-11-15","current":-143.716763,"twenty":-80.792913,"median":-56.569783,"eighty":-42.897746,"marketCap":35989321988},{"date":"2024-11-22","current":-149.571879,"twenty":-86.542136,"median":-57.071537,"eighty":-43.077872,"marketCap":37437808632},{"date":"2024-11-29","current":-163.214034,"twenty":-139.660525,"median":-57.926605,"eighty":-43.27892,"marketCap":40825038936},{"date":"2024-12-06","current":-164.492389,"twenty":-143.07608,"median":-58.601892,"eighty":-43.427612,"marketCap":41047883035},{"date":"2024-12-13","current":-167.859925,"twenty":-143.961595,"median":-59.46824,"eighty":-43.489321,"marketCap":41805552972},{"date":"2024-12-20","current":-160.518216,"twenty":-146.054141,"median":-61.493522,"eighty":-43.569737,"marketCap":39799956081},{"date":"2024-12-27","current":-154.616488,"twenty":-147.398806,"median":-62.556972,"eighty":-43.707223,"marketCap":38306900618},{"date":"2025-01-03","current":-146.467928,"twenty":-147.580179,"median":-62.909234,"eighty":-43.769457,"marketCap":36323588137},{"date":"2025-01-10","current":-149.189796,"twenty":-147.713941,"median":-63.270129,"eighty":-43.89543,"marketCap":36858413974},{"date":"2025-01-17","current":-146.545949,"twenty":-148.128618,"median":-63.821936,"eighty":-43.999852,"marketCap":36234450497},{"date":"2025-01-24","current":-151.096908,"twenty":-148.795989,"median":-64.223738,"eighty":-44.022873,"marketCap":37593799501},{"date":"2025-01-28","current":-144.751587,"twenty":-148.750633,"median":-64.3181,"eighty":-44.025895,"marketCap":36203787461},{"date":"2025-02-07","current":-162.755483,"twenty":-148.864023,"median":-64.816339,"eighty":-44.095348,"marketCap":40476425278},{"date":"2025-02-14","current":-166.856795,"twenty":-150.654332,"median":-65.202788,"eighty":-44.112421,"marketCap":41476404342},{"date":"2025-02-21","current":-194.414734,"twenty":-151.676932,"median":-65.382992,"eighty":-44.172115,"marketCap":48498984584},{"date":"2025-02-28","current":-211.14481,"twenty":-152.24965,"median":-65.712478,"eighty":-44.17615,"marketCap":52498900839},{"date":"2025-03-07","current":-225.41295,"twenty":-152.905086,"median":-66.309677,"eighty":-44.219461,"marketCap":56271549124},{"date":"2025-03-14","current":-227.151092,"twenty":-153.295015,"median":-66.812487,"eighty":-44.308071,"marketCap":56726085062},{"date":"2025-03-21","current":-236.708664,"twenty":-154.553256,"median":-67.337335,"eighty":-44.550078,"marketCap":59089671940},{"date":"2025-03-28","current":-231.805328,"twenty":-155.61149,"median":-67.803663,"eighty":-44.648429,"marketCap":66180441600},{"date":"2025-04-03","current":-246.46154,"twenty":-156.727441,"median":-67.952396,"eighty":-44.882152,"marketCap":70225812000},{"date":"2025-04-11","current":-242.489155,"twenty":-158.779779,"median":-68.515098,"eighty":-45.005591,"marketCap":68634936000},{"date":"2025-04-17","current":-228.611836,"twenty":-159.44307,"median":-68.80487,"eighty":-45.06217,"marketCap":64862287200},{"date":"2025-04-25","current":-235.137362,"twenty":-160.624501,"median":-68.953584,"eighty":-45.131919,"marketCap":66771338400},{"date":"2025-05-02","current":-274.570331,"twenty":-161.195254,"median":-69.468586,"eighty":-45.197413,"marketCap":78134738400},{"date":"2025-05-09","current":-249.374354,"twenty":-161.514906,"median":-70.050704,"eighty":-45.202208,"marketCap":71462875059},{"date":"2025-05-16","current":-247.507619,"twenty":-162.87029,"median":-70.732965,"eighty":-45.217068,"marketCap":71507400214},{"date":"2025-05-23","current":-244.618313,"twenty":-163.824551,"median":-71.32983,"eighty":-45.58151,"marketCap":70884048033},{"date":"2025-05-30","current":-244.159494,"twenty":-165.025774,"median":-71.669987,"eighty":-45.601984,"marketCap":71062148656},{"date":"2025-06-06","current":-258.187076,"twenty":-166.004403,"median":-72.203519,"eighty":-46.006494,"marketCap":75336563613},{"date":"2025-06-13","current":-271.678883,"twenty":-167.701589,"median":-72.488214,"eighty":-46.133909,"marketCap":79304691313},{"date":"2025-06-20","current":-252.757485,"twenty":-168.349452,"median":-72.789206,"eighty":-46.315126,"marketCap":73636805593},{"date":"2025-06-27","current":-255.806605,"twenty":-169.647858,"median":-73.569836,"eighty":-46.457129,"marketCap":74733815733},{"date":"2025-07-04","current":-283.173205,"twenty":-171.495185,"median":-73.869687,"eighty":-46.685504,"marketCap":82732847998},{"date":"2025-07-11","current":-266.231967,"twenty":-173.142078,"median":-74.539848,"eighty":-46.749361,"marketCap":77704884860},{"date":"2025-07-18","current":-304.526119,"twenty":-187.755426,"median":-75.01675,"eighty":-46.798833,"marketCap":88812112519},{"date":"2025-07-25","current":-289.211949,"twenty":-196.095673,"median":-75.38559,"eighty":-46.877904,"marketCap":84652615741},{"date":"2025-08-01","current":-318.351212,"twenty":-209.071662,"median":-75.715906,"eighty":-46.908544,"marketCap":92605939250},{"date":"2025-08-08","current":-315.832709,"twenty":-214.487876,"median":-76.34536,"eighty":-47.149906,"marketCap":92103142937},{"date":"2025-08-15","current":-340.637946,"twenty":-221.73884,"median":-77.157567,"eighty":-47.354138,"marketCap":99188000086},{"date":"2025-08-22","current":-135.707825,"twenty":-221.73884,"median":-78.335478,"eighty":-47.421279,"marketCap":106638527281},{"date":"2025-08-29","current":-131.473703,"twenty":-217.466422,"median":-78.819337,"eighty":-47.438439,"marketCap":103804584421},{"date":"2025-09-05","current":-151.82862,"twenty":-215.82299,"median":-80.340969,"eighty":-47.449348,"marketCap":119756940196},{"date":"2025-09-12","current":-146.494298,"twenty":-214.791029,"median":-81.555855,"eighty":-47.474394,"marketCap":115757424063},{"date":"2025-09-19","current":-147.466634,"twenty":-214.487876,"median":-85.53437,"eighty":-47.73502,"marketCap":116443055400},{"date":"2025-09-26","current":-143.954691,"twenty":-214.295448,"median":-89.950081,"eighty":-47.938811,"marketCap":113375018127},{"date":"2025-10-03","current":-165.853778,"twenty":-213.463042,"median":-128.34687,"eighty":-48.070155,"marketCap":130933921593},{"date":"2025-10-10","current":-144.531455,"twenty":-212.219938,"median":-131.729362,"eighty":-48.217901,"marketCap":113934664453},{"date":"2025-10-17","current":-135.703716,"twenty":-210.108236,"median":-132.867642,"eighty":-48.374971,"marketCap":106892448189},{"date":"2025-10-24","current":-129.499037,"twenty":-207.014216,"median":-133.546653,"eighty":-48.434282,"marketCap":102042180034},{"date":"2025-10-31","current":-132.379263,"twenty":-204.550971,"median":-132.326202,"eighty":-48.483234,"marketCap":104467314112},{"date":"2025-11-06","current":-121.699468,"twenty":-203.932949,"median":-132.129081,"eighty":-48.609184,"marketCap":95979344840}],"updateTime":1762479294226},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06990\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1171898813","title":"Sichuan Kelun-Biotech (06990) Releases Monthly Return for October 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1171898813","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171898813?lang=en_us&edition=fundamental","pubTime":"2025-11-05 16:44","pubTimestamp":1762332288,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (Stock Code: 06990) has released its Monthly Return on Movements in Securities for the period ended October 31, 2025. According to the return, the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"gpt_icon":0},{"id":"1133136868","title":"Merck Partners with Blackstone, Secures $700 Million to Accelerate Global Development of SKB BIO-B's (06990) Licensed Product Sac-TMT","url":"https://stock-news.laohu8.com/highlight/detail?id=1133136868","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133136868?lang=en_us&edition=fundamental","pubTime":"2025-11-04 20:56","pubTimestamp":1762260984,"startTime":"0","endTime":"0","summary":"On November 4, Merck took the rare step of launching a targeted financing initiative for sacituzumab govitecan (sac-TMT), securing $700 million from Blackstone to fund the drug's global development...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455194.USD","LU0234572021.USD","IE00BJT1NW94.SGD","LU1585245621.USD","LU1162221912.USD","LU0070302665.USD","LU1917777945.USD","BK4588","LU1571399168.USD","LU1934455863.HKD","SG9999001440.SGD","BK4007","LU0208291251.USD","LU2461242641.AUD","LU1066051811.HKD","LU1941712348.USD","LU1699723380.USD","LU0196878994.USD","LU1941712264.USD","LU1023059063.AUD","SG9999002224.SGD","BK4516","LU1934455277.USD","LU0985320562.USD","LU2089984988.USD","LU2361044865.SGD","LU1069347547.HKD","LU2023250504.SGD","LU1974910355.USD","LU1037948897.HKD","SGXZ57979304.SGD","BK1161","LU1066051225.USD","LU1291159041.SGD","BK4585","LU2023250843.SGD","SG9999014567.USD","IE00B2B36J28.USD","LU0265550946.USD","LU1093756168.USD","LU0289739699.SGD","LU1989771016.USD","BK4559","BK4534","LU0122379950.USD","LU2468319806.SGD","LU1983299246.USD","MRK","LU0266013472.USD","SG9999014575.USD","IE00BSNM7G36.USD","LU2106854487.HKD","IE00BLSP4239.USD","LU1066053197.SGD","LU0965509101.SGD","BK4533","06990","IE000M9KFDE8.USD","IE00BN8TJ469.HKD","LU1057294990.SGD","LU2112291526.USD","SG9999002232.USD","LU0203345920.USD","LU0861579265.USD","LU0098860793.USD","LU0965509283.SGD","SG9999015358.SGD","IE0009355771.USD","BK4550","LU0265550359.USD","SG9999015341.SGD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU1430594728.SGD","LU0965509010.AUD","LU0006306889.USD","LU2361044949.HKD","LU2324357040.USD","SG9999014559.SGD","LU0058720904.USD","LU0965508806.USD","SG9999001176.SGD","IE0002141913.USD","SG9999001176.USD","LU1037948541.HKD","IE00BLSP4452.SGD","LU1929549753.HKD","IE00B1BXHZ80.USD","LU0211331839.USD","LU0320765489.SGD","LU1066051498.USD","LU0320765646.SGD","LU1989772840.SGD","SG9999014542.SGD","IE00BFTCPJ56.SGD","LU1989772923.USD","LU1116320901.HKD","LU1061106388.HKD","LU1035773651.USD","LU1093756325.SGD","LU0106261372.USD","SG9999013999.USD","LU2361045086.USD","LU0238689110.USD","IE00BBT3K403.USD","LU1116320737.USD","LU0203347892.USD"],"gpt_icon":0},{"id":"2580521241","title":"Global Stocks That May Be Priced Below Their Estimated Value In November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2580521241","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580521241?lang=en_us&edition=fundamental","pubTime":"2025-11-03 17:08","pubTimestamp":1762160886,"startTime":"0","endTime":"0","summary":"As global markets navigate a complex landscape marked by mixed performances in major indices and shifting monetary policies, investors are closely watching for opportunities amid these fluctuations. The recent rate cuts by the Federal Reserve and the temporary trade truce between the U.S. and China have added layers of complexity to market dynamics, prompting a focus on stocks that may be undervalued relative to their estimated intrinsic value.\n\nIn this environment, identifying undervalued...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/3041000-choice1-main-header/1585186744280","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3041000-choice1-main-header/1585186744280"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/cn/capital-goods/shse-603929/lk-engineering-suzhoultd-shares/news/global-stocks-that-may-be-priced-below-their-estimated-value-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/cn/capital-goods/shse-603929/lk-engineering-suzhoultd-shares/news/global-stocks-that-may-be-priced-below-their-estimated-value-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"1137164093","title":"HK Stock Movement | SKB BIO-B (06990) Rises Nearly 5% as Core Product SKB264 Selected for Two Oral Presentations at ESMO","url":"https://stock-news.laohu8.com/highlight/detail?id=1137164093","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137164093?lang=en_us&edition=fundamental","pubTime":"2025-10-31 10:08","pubTimestamp":1761876494,"startTime":"0","endTime":"0","summary":"SKB BIO-B (06990) rose nearly 5%, with a 3.42% increase at the time of writing, trading at HK$436 and a turnover of HK$88.673 million. The company recently announced the release of multiple clinical...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"1182723392","title":"Jiaoyin International Maintains \"Buy\" Rating for SKB BIO-B (06990), Target Price Raised to HKD 549","url":"https://stock-news.laohu8.com/highlight/detail?id=1182723392","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182723392?lang=en_us&edition=fundamental","pubTime":"2025-10-22 14:40","pubTimestamp":1761115222,"startTime":"0","endTime":"0","summary":"Zhito Finance App reports that Jiaoyin International has released a research note stating that based on regulatory approval progress, there are more optimistic expectations for the sales of Sac-TMT...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2577874403","title":"A Look at Kelun-Biotech (SEHK:6990) Valuation Following Breakthrough ADC Trial Results and New China Approvals","url":"https://stock-news.laohu8.com/highlight/detail?id=2577874403","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577874403?lang=en_us&edition=fundamental","pubTime":"2025-10-21 20:23","pubTimestamp":1761049401,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) is catching plenty of attention after unveiling positive late-stage trial results for its lead ADC therapies at the 2025 ESMO Congress. With both trastuzumab botidotin and sacituzumab tirumotecan outperforming standard treatments in breast and lung cancer, as well as new regulatory approvals in China, investors are taking a fresh look at the company’s commercial prospects.\nSee our latest analysis for Sichuan Kelun-Biotech...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/a-look-at-kelun-biotech-sehk6990-valuation-following-breakth","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/a-look-at-kelun-biotech-sehk6990-valuation-following-breakth","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","BK4080","ADC","LU0196878994.USD","06990","BK4231","DCF"],"gpt_icon":0},{"id":"1159451449","title":"ESMO Shines! China's \"No. 1\" ADC Takes the Stage","url":"https://stock-news.laohu8.com/highlight/detail?id=1159451449","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159451449?lang=en_us&edition=fundamental","pubTime":"2025-10-20 20:26","pubTimestamp":1760963219,"startTime":"0","endTime":"0","summary":"Leaders never stop reaching new heights. Following Kolonbo Tai’s continuous business development (with a total transaction volume exceeding $10 billion), the industry has gradually witnessed the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","06990","LU0196878994.USD","BK1161","ADC","BK4080"],"gpt_icon":0},{"id":"2576883772","title":"Positive Results From Phase 3 Optitrop-Lung04 Trial of Sacituzumab Tirumotecan Presented at Esmo Presidential Symposium and Simultaneously Published in Nejm","url":"https://stock-news.laohu8.com/highlight/detail?id=2576883772","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576883772?lang=en_us&edition=fundamental","pubTime":"2025-10-20 10:01","pubTimestamp":1760925714,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nTUA345TMV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"1167493211","title":"HK Stock Movement | SKB BIO-B (06990) Opens Over 5% Higher, Announces Clinical Research Results at ESMO 2025 Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=1167493211","media":"Stock News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167493211?lang=en_us&edition=fundamental","pubTime":"2025-10-20 09:36","pubTimestamp":1760924188,"startTime":"0","endTime":"0","summary":"SKB BIO-B (06990) opened more than 5% higher, currently up 5.37% at HKD 483, with a trading volume of HKD 1.5939 million. The company announced that it presented several clinical research results at...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06990","LU0196878994.USD"],"gpt_icon":0},{"id":"1179884700","title":"SKB BIO-B (06990) Unveils Multiple Innovative Drug Research Findings at 2025 ESMO Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=1179884700","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179884700?lang=en_us&edition=fundamental","pubTime":"2025-10-20 08:22","pubTimestamp":1760919738,"startTime":"0","endTime":"0","summary":"SKB BIO-B (06990) announced that it presented several clinical research findings at the 2025 European Society for Medical Oncology (ESMO) conference held from October 17 to 21 in Berlin, Germany. The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK1574","06978","LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2576004457","title":"Sichuan Kelun-Biotech Unveils Positive Results from Multiple Innovative Drug Studies at 2025 ESMO Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2576004457","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576004457?lang=en_us&edition=fundamental","pubTime":"2025-10-20 07:32","pubTimestamp":1760916746,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. announced the presentation of results from multiple clinical studies at the 2025 European Society for Medical Oncology  Congress, held in Berlin, Germany from October 17 to 21, 2025. The studies included data on sacituzumab tirumotecan , a TROP2-directed antibody-drug conjugate , trastuzumab botidotin , a HER2-directed ADC, and SKB315, a Claudin18.2 ADC. Two studies of sac-TMT were selected for Late Breaking Abstract oral presentation, including a Phase 3 study in EGFR-mutated non-small cell lung cancer following progression on EGFR-tyrosine kinase inhibitors. The company also reported ongoing research on SKB315 in combination with immunotherapy and as monotherapy in tumors expressing Claudin18.2. The company cautioned that these drugs are not yet approved for all indications and may not ultimately be successfully developed or commercialized.Disclaimer: This news brief was created by Public Technologies  using generative artificial inte","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251019:nNDL7FfVX3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","06990","BK0060","LU1064130708.USD","LU1934453819.USD","LU2148510915.USD","LU0196878994.USD","002422","LU1064131003.USD","LU1979443071.USD","BK1161"],"gpt_icon":0},{"id":"2576017137","title":"Kelun-Biotech Reports Positive Phase 3 Results for Sacituzumab Tirumotecan in Advanced HR+/HER2- Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2576017137","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576017137?lang=en_us&edition=fundamental","pubTime":"2025-10-18 22:42","pubTimestamp":1760798574,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has announced positive results from the Phase 3 OptiTROP-Breast02 clinical study evaluating sacituzumab tirumotecan , a TROP2-directed antibody-drug conjugate, in patients with previously treated locally advanced or metastatic hormone receptor-positive (HR+)/HER2-negative breast cancer. The results were presented at the 2025 European Society for Medical Oncology  Congress in Berlin, Germany. The study demonstrated that sac-TMT achieved statistically significant and clinically meaningful improvement in progression-free survival compared to chemotherapy, with benefits observed across all predefined subgroups and independent of HER2 status. Sac-TMT also showed a trend toward overall survival benefit and had a favorable and manageable safety profile with no new safety signals reported. Additional Phase III clinical studies of sac-TMT as monotherapy and in combination with pembrolizumab are ongoing globally and in China.Disclaimer: This news","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251018:nNDL8byc79:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","LU2148510915.USD","LU1979443071.USD","LU0196878994.USD","LU1064130708.USD","LU1934453819.USD","06990","LU1064131003.USD","BK1161","BK0060","002422"],"gpt_icon":0},{"id":"2576201038","title":"Sichuan Kelun-Biotech’s Trastuzumab Botidotin Receives NMPA Approval for HER2-Positive Metastatic Breast Cancer in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2576201038","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576201038?lang=en_us&edition=fundamental","pubTime":"2025-10-17 17:42","pubTimestamp":1760694154,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. announced that its core product, trastuzumab botidotin , a HER2-directed antibody-drug conjugate , has been approved for marketing by the National Medical Products Administration  for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer who have received one or more prior anti-HER2 therapies. The approval is based on results from a Phase 3 clinical study demonstrating significant improvement in progression-free survival compared to T-DM1. Trastuzumab botidotin is the first domestically developed HER2 ADC in China capable of broadly covering second-line and later HER2-positive breast cancer patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Si","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nNDL57rz6b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1979443071.USD","LU2148510915.USD","LU0196878994.USD","BK0239","LU1064131003.USD","BK1161","LU1064130708.USD","BK0060","06990","LU1934453819.USD","002422"],"gpt_icon":0},{"id":"1114574700","title":"Kelun-Biotech (6990) Secures NMPA Approval for Trastuzumab Botidotin in HER2+ Metastatic Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1114574700","media":"Bulletin Express","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114574700?lang=en_us&edition=fundamental","pubTime":"2025-10-17 16:48","pubTimestamp":1760690936,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (Stock Code: 6990) has announced that its core human epidermal growth factor receptor 2 (HER2)-directed antibody-drug conjugate, trastuzumab...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"gpt_icon":0},{"id":"1187460844","title":"SKB BIO-B (06990): Core Product A166 Approved by NMPA for 2L+ HER2+ Breast Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1187460844","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187460844?lang=en_us&edition=fundamental","pubTime":"2025-10-17 16:46","pubTimestamp":1760690792,"startTime":"0","endTime":"0","summary":"SKB BIO-B (06990) announced that its antibody-drug conjugate (ADC) A166 (also known as 博度曲妥珠單抗) has received approval from the National Medical Products Administration (NMPA) for the treatment of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2576826490","title":"BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Says NMPA Approves Trastuzumab Botidotin For Marketing","url":"https://stock-news.laohu8.com/highlight/detail?id=2576826490","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576826490?lang=en_us&edition=fundamental","pubTime":"2025-10-17 16:38","pubTimestamp":1760690294,"startTime":"0","endTime":"0","summary":"BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Says NMPA Approves Trastuzumab Botidotin For MarketingOct 17 (Reuters) - Sichuan Kelun-Biotech Biopharmaceutical Co Ltd 6990.HK:NMPA APPROVES TRASTUZUMAB BOTIDOTIN FOR MARKETINGFurther company coverage: 6990.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nFWN3VX2RW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2576082667","title":"Sichuan Kelun-Biotech Biopharmaceutical Co Ltd - Nmpa Approves Trastuzumab Botidotin for Marketing","url":"https://stock-news.laohu8.com/highlight/detail?id=2576082667","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576082667?lang=en_us&edition=fundamental","pubTime":"2025-10-17 16:36","pubTimestamp":1760690162,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nFWN3VX2RW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"1118666243","title":"Analysis of Hong Kong Stocks | Favorable Conditions Strengthen Exchange Rates, Market Blossoms, Pharmaceuticals Worthy of Exploitation","url":"https://stock-news.laohu8.com/highlight/detail?id=1118666243","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118666243?lang=en_us&edition=fundamental","pubTime":"2025-10-15 20:20","pubTimestamp":1760530852,"startTime":"0","endTime":"0","summary":"【Market Analysis】The current stock market is witnessing a tug-of-war effect; following a lackluster rise in the US stock market yesterday, domestic markets began to strengthen today. The Hong Kong...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","LU0348783233.USD","IE00BZ08YT58.USD","LU1282651121.HKD","LU0417516738.SGD","SG9999002828.SGD","IE00BPRC5H50.USD","GELYY","LU0348735423.USD","IE00B0JY6N72.USD","LU0293314216.USD","LU0196878994.USD","LU0561508036.HKD","09939","IE00B5MMRT66.SGD","LU2360107325.USD","LU2399975544.HKD","LU1720050803.USD","BK1539","LU2476274720.SGD","IE00BZ08YR35.GBP","LU0417516571.SGD","09926","IE00B543WZ88.USD","LU0348784397.USD","BK1589","BK1161","LU0348767384.USD","BK1515","LU1861219969.SGD","159938","LU0315179316.USD","BK1119","LU0348766576.USD","LU0540923850.HKD","LU0634319403.HKD","LU1794554557.SGD","LU2778985437.USD","BK1574","80175","LU2488822045.USD","LU1224444064.USD","BK1521","IE00BZ08YS42.EUR","LU1961090484.USD","LU0417516902.SGD","LU1282651048.USD","EVS.SI","00175","LU0348827113.USD","LU1861214812.USD","LU0348825331.USD","LU2476274308.USD"],"gpt_icon":0},{"id":"1120022384","title":"Hong Kong Stocks Movement | Pharmaceutical Stocks Continue Multi-Day Decline Amid Short-Term External Environment Changes, Institutions Remain Optimistic About Long-Term Industry Development Trends","url":"https://stock-news.laohu8.com/highlight/detail?id=1120022384","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120022384?lang=en_us&edition=fundamental","pubTime":"2025-10-14 14:30","pubTimestamp":1760423428,"startTime":"0","endTime":"0","summary":"Pharmaceutical stocks have continued their sluggish performance over consecutive days, with declines expanding further in the afternoon session. As of press time, VIVA BIOTECH (01873) dropped 7.53%...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02162","LU0196878994.USD","09939","BK1515","BK1574","06990","BK1576","BK1583","BK1587","01672","159938","01873","BK1141","BK1161"],"gpt_icon":0},{"id":"1112162381","title":"Hong Kong Stock Morning Brief | Congo's Cobalt Export Quota Takes Effect, Qualcomm Under Antitrust Investigation","url":"https://stock-news.laohu8.com/highlight/detail?id=1112162381","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112162381?lang=en_us&edition=fundamental","pubTime":"2025-10-13 07:06","pubTimestamp":1760310417,"startTime":"0","endTime":"0","summary":"**Today's Headlines** **Congo's Cobalt Export Quota Implementation** On October 11, Congo's cobalt export quota was announced. Congo is strengthening resource sovereignty through a quota system,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1242","IE00BGHQDM52.EUR","LU0868494617.USD","BK4588","BK1580","LU0061475181.USD","SG9999015952.SGD","SG9999015986.USD","BK1198","01521","07226","BK4575","LU0196878994.USD","LU1035775433.USD","BK4614","BK4534","BK4512","BK4561","BK1583","LU1823568750.SGD","BK1161","LU1917777945.USD","LU2247934214.USD","BK1576","BK4532","HSTECH","01818","IE00BVYPNQ40.USD","LU2023250504.SGD","BK4515","LU0081259029.USD","BK4581","BK4141","BK1544","06680","BK4573","LU0868494708.USD","BK1592","LU1119994496.HKD","BK1148","LU0942090050.USD","06990","BK1141","06969","BK4579","LU2106854487.HKD","LU1084165304.USD","BK4612","03996","BK4554","IE00BSNM7G36.USD","SG9999015978.USD","BK4604","LU1046421795.USD","SG9999015945.SGD","GB00BDT5M118.USD","BK4585","BK1116","BK4605","BK1589","HSCEI","BK4598","LU0079474960.USD","YANG","IE00BVYPNP33.GBP","SG9999001424.SGD","BK4527","LU1974910355.USD","QCOM","LU1069344957.HKD","LU1261432733.SGD"],"gpt_icon":1}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":73,"code":"91000000","status":"200"}]}}